In summary, we have identified the critical role and molecular mechanisms of NEAT1-mediated glutamine metabolism and FLSs-RA dysfunction through the regulation of the miR-338-3p-GLS pathway, and targeting glutamine metabolism by non-coding RNAs to inhibit FLSs overgrowth for the treatment of RA. The gene discussed is NEAT1; the disease is rheumatoid arthritis.